AGENDIA N V has a total of 11 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology are ZHUHAI ENCODE MEDICAL ENGINEERING CO LTD, RUIJIN HOSPITAL AFFILIATED TO and TIANJIN KERUN AGRICULTURAL SCIENCE & TECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | United States | 2 | |
#4 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Glas Annuska Maria | 9 |
#2 | Roepman Paul | 9 |
#3 | Simon Iris | 7 |
#4 | Sun Tian | 7 |
#5 | Bernards Rene | 6 |
#6 | Van T Veer Laura Johanna | 1 |
#7 | Floore Arno Nicolaas | 1 |
#8 | Krijgsman Oscar | 1 |
#9 | Tian Sun | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018128544A1 | Biomarkers for selecting patient groups, and uses thereof. | |
US2016115552A1 | Means and methods for molecular classification of breast cancer | |
EP2655661A2 | Methods and means for molecular classification of colorectal cancers | |
AU2011308134A1 | Methods and means for typing a sample comprising cancer cells based on oncogenic signal transduction pathways | |
EP2084296A2 | High-throughput diagnostic testing using arrays |